Review



human il 15  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Miltenyi Biotec human il 15
    Human Il 15, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 185 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+15/Human+IL-15%2C+premium+grade/pm42906542-1041-56-58
    Average 96 stars, based on 185 article reviews
    human il 15 - by Bioz Stars, 2026-11
    96/100 stars

    Images

    Related Articles

    other:

    Article Title: Respiratory syncytial virus inhibits type I interferon signaling to maintain HLA-DM expression in CD1c+ dendritic cells
    Article Snippet: Blood was diluted with prewarmed PBS(Gibco, cat#10010-023) (supplemented with 0.4% of EDTA (Invitrogen, Thermofisher scientific, cat#AM9260G)).

    Article Title: Chimeric allergen receptor regulatory T cells suppress birch pollen allergic airway inflammation.
    Article Snippet: T cells were activated with mouse anti-CD3/CD28 Dynabeads (Cat. #11452D; Gibco) at 1:1 bead-to-cell ratio for conventional T cells and at 3:1 ratio for Tregs.

    Cell Culture:

    Article Title: Method for gene transfer into gamma-delta type T cell
    Article Snippet: .. The monocytes adjusted to 1.5×106 cells/mL with the culture solution of Yssel containing 10% human AB serum were cultured for one day in the presence of tetrakispivaloyloxymethyl 2-(thiazole-2-ylamino) ethylidene-1,1-bisphosphonate (compound 7, 1 μM), and then added with 25 ng/mL of IL-7 (Miltenyi Biotec, catalog number: 170-076-111) and 25 ng/mL of IL-15 (Miltenyi Biotec, catalog number: 170-076-114), and further cultured for 10 days. .. The frequency of the γδT cells in the monocyte population were analyzed by flow cytometry (FACSCANTO II, Becton Dickinson).

    Article Title: Functional heterogeneity of CAR-T cells revealed by multimodal imaging of activation dynamics
    Article Snippet: .. CD3+ T cells have been isolated through Pan-T cell isolation kit (MiltenyiBiotec, Germany) and cultured in α-MEM 20%FBS supplemented with 10 ng/mL IL7 (Cat# 130-095-367, MiltenyiBiotec), 10 ng/mL IL-15 (Cat# 130-095-760, MiltenyiBiotec) and stimulated for 48/72 hours with T Cell TransAct (Cat#130-128-758 MiltenyiBiotec). .. CD3+ cells were then transduced with CD19.CAR-T lentiviral vector at multiplicity of infection (MOI) 50 and cultured in retronectin (Takara Bio, California, USA) coated wells.

    Article Title: Functional diversity of Vγ9Vδ2 T cells overcomes glioblastoma state plasticity and antigen heterogeneity
    Article Snippet: At day 3 of the culture, 100 IU/mL of recombinant IL-2 (Proleukin Clinigen) was added. .. From day 6, Vδ2T cells were cultured with 100 IU/mL IL-2 and 100 U/ml IL-15 (Miltenyi Biotec 130-095-760). ..

    Isolation:

    Article Title: Functional heterogeneity of CAR-T cells revealed by multimodal imaging of activation dynamics
    Article Snippet: .. CD3+ T cells have been isolated through Pan-T cell isolation kit (MiltenyiBiotec, Germany) and cultured in α-MEM 20%FBS supplemented with 10 ng/mL IL7 (Cat# 130-095-367, MiltenyiBiotec), 10 ng/mL IL-15 (Cat# 130-095-760, MiltenyiBiotec) and stimulated for 48/72 hours with T Cell TransAct (Cat#130-128-758 MiltenyiBiotec). .. CD3+ cells were then transduced with CD19.CAR-T lentiviral vector at multiplicity of infection (MOI) 50 and cultured in retronectin (Takara Bio, California, USA) coated wells.

    Cell Isolation:

    Article Title: Functional heterogeneity of CAR-T cells revealed by multimodal imaging of activation dynamics
    Article Snippet: .. CD3+ T cells have been isolated through Pan-T cell isolation kit (MiltenyiBiotec, Germany) and cultured in α-MEM 20%FBS supplemented with 10 ng/mL IL7 (Cat# 130-095-367, MiltenyiBiotec), 10 ng/mL IL-15 (Cat# 130-095-760, MiltenyiBiotec) and stimulated for 48/72 hours with T Cell TransAct (Cat#130-128-758 MiltenyiBiotec). .. CD3+ cells were then transduced with CD19.CAR-T lentiviral vector at multiplicity of infection (MOI) 50 and cultured in retronectin (Takara Bio, California, USA) coated wells.

    Activation Assay:

    Article Title: Extracellular matrix–targeted TNC-scFv armoring enhances CAR T cell persistence and antitumor activity in solid tumors
    Article Snippet: CD3 + T cells were then separated using a Human T Cell Isolation Kit (17951, STEMCELL, Canada). .. CD3 + T cells were activated with activation beads (11132D, Gibco, USA) in culture solution with recombinant human IL-7 (170-076-184, Miltenyi Biotec, USA) and IL-15 (170-076-186, Miltenyi Biotec, USA). .. T cells were infected with lentiviral vectors 24 hours postseeding in the presence of polybrene (TR-1003-G, Merck, Germany).

    Recombinant:

    Article Title: Extracellular matrix–targeted TNC-scFv armoring enhances CAR T cell persistence and antitumor activity in solid tumors
    Article Snippet: CD3 + T cells were then separated using a Human T Cell Isolation Kit (17951, STEMCELL, Canada). .. CD3 + T cells were activated with activation beads (11132D, Gibco, USA) in culture solution with recombinant human IL-7 (170-076-184, Miltenyi Biotec, USA) and IL-15 (170-076-186, Miltenyi Biotec, USA). .. T cells were infected with lentiviral vectors 24 hours postseeding in the presence of polybrene (TR-1003-G, Merck, Germany).



    Similar Products

    96
    Miltenyi Biotec human il 15
    Human Il 15, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+15/Human+IL-15%2C+premium+grade/pm42906542-1041-56-58
    Average 96 stars, based on 1 article reviews
    human il 15 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    Sino Biological il 15 cx
    Il 15 Cx, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+15/Mouse+IL15+%26+IL15RA+Heterodimer+Protein/pm42855600-367-4-8
    Average 94 stars, based on 1 article reviews
    il 15 cx - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    97
    InvivoGen hek blue il
    Hek Blue Il, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+15/HEK-Blue+IL-2+Cells/pmc13767619-165-0-6
    Average 97 stars, based on 1 article reviews
    hek blue il - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    94
    Proteintech human il 15 elisa kit
    Human Il 15 Elisa Kit, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+15/Human+IL-15+ELISA+Kit/10__1038_slash_s41598___026___76311___4-78-17-45
    Average 94 stars, based on 1 article reviews
    human il 15 elisa kit - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    Bio X Cell anti il 15 antibody
    (A) Abundance plots for co-occurring CD8+ T cell and Tnc -Hi iFB states nominated by proportionality network in Fig 2J. (B) Violin plot showing expression of T1 and T2 cytokine receptors along with selected differentially expressed markers of iFB states. (C) Flow cytometry was used to determine IL-15Rα positivity across CD31+ endothelial, CD45+ immune, PDGFRα+ fibroblasts and Ep-CAM+ epithelial cells (n=4 mice). Schematic and D37 ear thickness of <t>IL-15</t> blockade prior to T2 memory (n=8 mice/group). Abundance of CD8+ T cells in D37 skin measured by flow cytometry (n=5 (Iso), 4 (α-IL-15) mice). (F) gMFI of IL-15-mediated support markers GZMB , IFNγ and Ki-67 in CD103+ and CD103-CD8+ T cells on D37 (n=3 (Iso), 4 (α-IL-15) mice). (G) Schematic of primary ear skin fibroblast isolation for cytokine stimulation. Heatmap of Il15ra and Il15 expression scaled as z-score across cytokine stimulation conditions (n=4 (IFNγ/TNF-α), 8 (single cytokine) mice). (H) Representative pSTAT1 staining in D37 skin from PDGFRα-eGFP mice. Yellow arrowheads denote pSTAT1+ PDGFRα+ fibroblasts. Schematic of intradermal AAV administration for STAT1 signaling modulation prior to T2 recall with associated ear thicknesses on D37 (n=7 (GFP, STAT1ca), 6 (STAT1dn) mice). FLAG-STAT1ca+ PDGFRa+ fibroblasts were compared with FLAG-untransduced fibroblasts for IL-15Rα gMFI on D37 (n=4 mice). (K) Frequency of GZMB positivity (n=11(GFP), 8 (STAT1ca) mice) and (L) GZMB gMFI were measured in CD103+ Trm cells and CD103-recruited cells on D37 in AAV-injected mice (n=15 (GFP), 12 (STAT1ca) mice). (M) UMAP embedding of 97,393 fibroblasts across 70 patients and 5 studies where subtypes are annotated (reticular rFB, papillary pFB, immune-interacting iiFB, nerve-associated nFB and hair follicle-associated hFB) and clusters are coloured. Study information is provided in and cluster definitions in . (N) Mapping of the top 50 genes defining murine Tnc -Hi iFB subtype as a gene module across human fibroblast clusters using patient-level pseudobulk GSVA. (O) Cell cluster abundances were correlated against vIGA-AD scores. Significant associations are highlighted. (P) Quantification of IL4I1 + pFB abundance in biopsies across healthy (H), non-lesional (NL) and lesional (L) skin (n=19 (H), 20 (NL), 31 (L) patients). (Q) Violin plot of genes stimulated by T2 and T1 effector cytokines across severity-associated human fibroblast clusters.
    Anti Il 15 Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+15/InVivoMAb+anti-mouse+IL-15/bio_rxiv__64898__2026__11__02__763646-442-11-13
    Average 93 stars, based on 1 article reviews
    anti il 15 antibody - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    R&D Systems murine il 15
    A. Schematic for MHC Class I immunoprecipitation from B16-F10, B16-(shRNA-AIRE), and B16-F10-(AIRE) cells using the Clone Y-3 anti-H-2K b antibody (Created in BioRender. Chen, A. (2026) https://BioRender.com/grw7tkh ). B. C57BL/6 mice with 5 day-established B16-F10 tumors (n=8 mice per group) were treated with dendritic cells loaded in vitro with SIINFEKL peptide (1 μg per 1 × 10 6 DC/injection) with PBS or with peptide sets of the Unique, Shared, Longer peptides (see Table 1 ) (at 0.25 μg per peptide, total 1 μg per 1 × 10 6 DC/injection) on days 5, 7 & 9. Mice were then treated with anti-PD-1 antibody or isotype IgG control as shown on days 12, 14, 16 and 19, 21, 23. For clarity, survival and tumor volume with time are shown for groups treated with control IgG (no ICB) ( B ) or with ICB ( C ) ( B & C are the same experiment). D. CD8 + T cells (1 × 10 6 /well) were isolated from mice at endpoint in B/C. (4/group) which had been treated with DC vaccines loaded with different peptides and co-treated with anti-PD-1 as shown. 1 × 10 6 CD8 + T cells were re-stimulated in 96-well ELISPOT plates (4 biological triplicates shown) with either 5 × 10 5 live target cells (B16-F10 or B16-F10-(AIRE) (pre-treated with IFN-γ for 24 hours to increase MHC class I expression) or with either 5 × 10 5 dendritic cells loaded with the Unique, Shared, Longer peptide sets or SIINFEKL peptide (total of 1 μg peptide/10 6 DC) for 48 hours at 37°C. IFN-γ positive spots were quantified by computer assisted image analyzer. Mean values are shown for four biological triplicates and error bars represent standard deviation of the mean. E. CD4 + T cells were isolated by magnetic bead sorting from mice at endpoint in B/C (3/group) which had been treated with DC vaccines loaded with different peptides and co-treated with anti-PD-1 as shown. 5 × 10 5 CD4 + T cells were re-stimulated in 96-well plates (3 biological triplicates shown) with 5 × 10 5 dendritic cells loaded with the Longer ( i ), Shared ( ii ), or Unique ( iii ) peptide sets (total of 1 μg peptide/10 6 DC) for 48 hours at 37°C. 48 hours <t>later</t> <t>IL-15</t> in the supernatant was measured by ELISA (Bio-Techne, R&D Systems; Mouse IL-15 DuoSet ELISA; Cat# <t>DY447).</t> Mean values are shown for three biological triplicates and error bars represent standard deviation of the mean. Gehan-Breslow-Wilcoxon statistical tests for survival were used for B & C , and ordinary one-way ANOVA statistical tests were used to analyze D & E (α=0.05).
    Murine Il 15, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+15/Mouse+IL-15+DuoSet+ELISA/pmc13737429-102-12-15
    Average 93 stars, based on 1 article reviews
    murine il 15 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    97
    InvivoGen hek bluetm il 2 cells
    A. Schematic for MHC Class I immunoprecipitation from B16-F10, B16-(shRNA-AIRE), and B16-F10-(AIRE) cells using the Clone Y-3 anti-H-2K b antibody (Created in BioRender. Chen, A. (2026) https://BioRender.com/grw7tkh ). B. C57BL/6 mice with 5 day-established B16-F10 tumors (n=8 mice per group) were treated with dendritic cells loaded in vitro with SIINFEKL peptide (1 μg per 1 × 10 6 DC/injection) with PBS or with peptide sets of the Unique, Shared, Longer peptides (see Table 1 ) (at 0.25 μg per peptide, total 1 μg per 1 × 10 6 DC/injection) on days 5, 7 & 9. Mice were then treated with anti-PD-1 antibody or isotype IgG control as shown on days 12, 14, 16 and 19, 21, 23. For clarity, survival and tumor volume with time are shown for groups treated with control IgG (no ICB) ( B ) or with ICB ( C ) ( B & C are the same experiment). D. CD8 + T cells (1 × 10 6 /well) were isolated from mice at endpoint in B/C. (4/group) which had been treated with DC vaccines loaded with different peptides and co-treated with anti-PD-1 as shown. 1 × 10 6 CD8 + T cells were re-stimulated in 96-well ELISPOT plates (4 biological triplicates shown) with either 5 × 10 5 live target cells (B16-F10 or B16-F10-(AIRE) (pre-treated with IFN-γ for 24 hours to increase MHC class I expression) or with either 5 × 10 5 dendritic cells loaded with the Unique, Shared, Longer peptide sets or SIINFEKL peptide (total of 1 μg peptide/10 6 DC) for 48 hours at 37°C. IFN-γ positive spots were quantified by computer assisted image analyzer. Mean values are shown for four biological triplicates and error bars represent standard deviation of the mean. E. CD4 + T cells were isolated by magnetic bead sorting from mice at endpoint in B/C (3/group) which had been treated with DC vaccines loaded with different peptides and co-treated with anti-PD-1 as shown. 5 × 10 5 CD4 + T cells were re-stimulated in 96-well plates (3 biological triplicates shown) with 5 × 10 5 dendritic cells loaded with the Longer ( i ), Shared ( ii ), or Unique ( iii ) peptide sets (total of 1 μg peptide/10 6 DC) for 48 hours at 37°C. 48 hours <t>later</t> <t>IL-15</t> in the supernatant was measured by ELISA (Bio-Techne, R&D Systems; Mouse IL-15 DuoSet ELISA; Cat# <t>DY447).</t> Mean values are shown for three biological triplicates and error bars represent standard deviation of the mean. Gehan-Breslow-Wilcoxon statistical tests for survival were used for B & C , and ordinary one-way ANOVA statistical tests were used to analyze D & E (α=0.05).
    Hek Bluetm Il 2 Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+15/HEK-Blue+IL-2+Cells/pm42962667-280-41-44
    Average 97 stars, based on 1 article reviews
    hek bluetm il 2 cells - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    94
    R&D Systems recombinant human il 2
    A. Schematic for MHC Class I immunoprecipitation from B16-F10, B16-(shRNA-AIRE), and B16-F10-(AIRE) cells using the Clone Y-3 anti-H-2K b antibody (Created in BioRender. Chen, A. (2026) https://BioRender.com/grw7tkh ). B. C57BL/6 mice with 5 day-established B16-F10 tumors (n=8 mice per group) were treated with dendritic cells loaded in vitro with SIINFEKL peptide (1 μg per 1 × 10 6 DC/injection) with PBS or with peptide sets of the Unique, Shared, Longer peptides (see Table 1 ) (at 0.25 μg per peptide, total 1 μg per 1 × 10 6 DC/injection) on days 5, 7 & 9. Mice were then treated with anti-PD-1 antibody or isotype IgG control as shown on days 12, 14, 16 and 19, 21, 23. For clarity, survival and tumor volume with time are shown for groups treated with control IgG (no ICB) ( B ) or with ICB ( C ) ( B & C are the same experiment). D. CD8 + T cells (1 × 10 6 /well) were isolated from mice at endpoint in B/C. (4/group) which had been treated with DC vaccines loaded with different peptides and co-treated with anti-PD-1 as shown. 1 × 10 6 CD8 + T cells were re-stimulated in 96-well ELISPOT plates (4 biological triplicates shown) with either 5 × 10 5 live target cells (B16-F10 or B16-F10-(AIRE) (pre-treated with IFN-γ for 24 hours to increase MHC class I expression) or with either 5 × 10 5 dendritic cells loaded with the Unique, Shared, Longer peptide sets or SIINFEKL peptide (total of 1 μg peptide/10 6 DC) for 48 hours at 37°C. IFN-γ positive spots were quantified by computer assisted image analyzer. Mean values are shown for four biological triplicates and error bars represent standard deviation of the mean. E. CD4 + T cells were isolated by magnetic bead sorting from mice at endpoint in B/C (3/group) which had been treated with DC vaccines loaded with different peptides and co-treated with anti-PD-1 as shown. 5 × 10 5 CD4 + T cells were re-stimulated in 96-well plates (3 biological triplicates shown) with 5 × 10 5 dendritic cells loaded with the Longer ( i ), Shared ( ii ), or Unique ( iii ) peptide sets (total of 1 μg peptide/10 6 DC) for 48 hours at 37°C. 48 hours <t>later</t> <t>IL-15</t> in the supernatant was measured by ELISA (Bio-Techne, R&D Systems; Mouse IL-15 DuoSet ELISA; Cat# <t>DY447).</t> Mean values are shown for three biological triplicates and error bars represent standard deviation of the mean. Gehan-Breslow-Wilcoxon statistical tests for survival were used for B & C , and ordinary one-way ANOVA statistical tests were used to analyze D & E (α=0.05).
    Recombinant Human Il 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+15/Recombinant+Human+IL-15+Protein%2C+CF/pmc13771879-135-20-24
    Average 94 stars, based on 1 article reviews
    recombinant human il 2 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec il 15
    A. Schematic for MHC Class I immunoprecipitation from B16-F10, B16-(shRNA-AIRE), and B16-F10-(AIRE) cells using the Clone Y-3 anti-H-2K b antibody (Created in BioRender. Chen, A. (2026) https://BioRender.com/grw7tkh ). B. C57BL/6 mice with 5 day-established B16-F10 tumors (n=8 mice per group) were treated with dendritic cells loaded in vitro with SIINFEKL peptide (1 μg per 1 × 10 6 DC/injection) with PBS or with peptide sets of the Unique, Shared, Longer peptides (see Table 1 ) (at 0.25 μg per peptide, total 1 μg per 1 × 10 6 DC/injection) on days 5, 7 & 9. Mice were then treated with anti-PD-1 antibody or isotype IgG control as shown on days 12, 14, 16 and 19, 21, 23. For clarity, survival and tumor volume with time are shown for groups treated with control IgG (no ICB) ( B ) or with ICB ( C ) ( B & C are the same experiment). D. CD8 + T cells (1 × 10 6 /well) were isolated from mice at endpoint in B/C. (4/group) which had been treated with DC vaccines loaded with different peptides and co-treated with anti-PD-1 as shown. 1 × 10 6 CD8 + T cells were re-stimulated in 96-well ELISPOT plates (4 biological triplicates shown) with either 5 × 10 5 live target cells (B16-F10 or B16-F10-(AIRE) (pre-treated with IFN-γ for 24 hours to increase MHC class I expression) or with either 5 × 10 5 dendritic cells loaded with the Unique, Shared, Longer peptide sets or SIINFEKL peptide (total of 1 μg peptide/10 6 DC) for 48 hours at 37°C. IFN-γ positive spots were quantified by computer assisted image analyzer. Mean values are shown for four biological triplicates and error bars represent standard deviation of the mean. E. CD4 + T cells were isolated by magnetic bead sorting from mice at endpoint in B/C (3/group) which had been treated with DC vaccines loaded with different peptides and co-treated with anti-PD-1 as shown. 5 × 10 5 CD4 + T cells were re-stimulated in 96-well plates (3 biological triplicates shown) with 5 × 10 5 dendritic cells loaded with the Longer ( i ), Shared ( ii ), or Unique ( iii ) peptide sets (total of 1 μg peptide/10 6 DC) for 48 hours at 37°C. 48 hours <t>later</t> <t>IL-15</t> in the supernatant was measured by ELISA (Bio-Techne, R&D Systems; Mouse IL-15 DuoSet ELISA; Cat# <t>DY447).</t> Mean values are shown for three biological triplicates and error bars represent standard deviation of the mean. Gehan-Breslow-Wilcoxon statistical tests for survival were used for B & C , and ordinary one-way ANOVA statistical tests were used to analyze D & E (α=0.05).
    Il 15, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+15/MACS+GMP+Recombinant+Human+IL-15/pmc13651853-267-24-26
    Average 94 stars, based on 1 article reviews
    il 15 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    97
    InvivoGen hek blue il 2 reporter system
    A. Schematic for MHC Class I immunoprecipitation from B16-F10, B16-(shRNA-AIRE), and B16-F10-(AIRE) cells using the Clone Y-3 anti-H-2K b antibody (Created in BioRender. Chen, A. (2026) https://BioRender.com/grw7tkh ). B. C57BL/6 mice with 5 day-established B16-F10 tumors (n=8 mice per group) were treated with dendritic cells loaded in vitro with SIINFEKL peptide (1 μg per 1 × 10 6 DC/injection) with PBS or with peptide sets of the Unique, Shared, Longer peptides (see Table 1 ) (at 0.25 μg per peptide, total 1 μg per 1 × 10 6 DC/injection) on days 5, 7 & 9. Mice were then treated with anti-PD-1 antibody or isotype IgG control as shown on days 12, 14, 16 and 19, 21, 23. For clarity, survival and tumor volume with time are shown for groups treated with control IgG (no ICB) ( B ) or with ICB ( C ) ( B & C are the same experiment). D. CD8 + T cells (1 × 10 6 /well) were isolated from mice at endpoint in B/C. (4/group) which had been treated with DC vaccines loaded with different peptides and co-treated with anti-PD-1 as shown. 1 × 10 6 CD8 + T cells were re-stimulated in 96-well ELISPOT plates (4 biological triplicates shown) with either 5 × 10 5 live target cells (B16-F10 or B16-F10-(AIRE) (pre-treated with IFN-γ for 24 hours to increase MHC class I expression) or with either 5 × 10 5 dendritic cells loaded with the Unique, Shared, Longer peptide sets or SIINFEKL peptide (total of 1 μg peptide/10 6 DC) for 48 hours at 37°C. IFN-γ positive spots were quantified by computer assisted image analyzer. Mean values are shown for four biological triplicates and error bars represent standard deviation of the mean. E. CD4 + T cells were isolated by magnetic bead sorting from mice at endpoint in B/C (3/group) which had been treated with DC vaccines loaded with different peptides and co-treated with anti-PD-1 as shown. 5 × 10 5 CD4 + T cells were re-stimulated in 96-well plates (3 biological triplicates shown) with 5 × 10 5 dendritic cells loaded with the Longer ( i ), Shared ( ii ), or Unique ( iii ) peptide sets (total of 1 μg peptide/10 6 DC) for 48 hours at 37°C. 48 hours <t>later</t> <t>IL-15</t> in the supernatant was measured by ELISA (Bio-Techne, R&D Systems; Mouse IL-15 DuoSet ELISA; Cat# <t>DY447).</t> Mean values are shown for three biological triplicates and error bars represent standard deviation of the mean. Gehan-Breslow-Wilcoxon statistical tests for survival were used for B & C , and ordinary one-way ANOVA statistical tests were used to analyze D & E (α=0.05).
    Hek Blue Il 2 Reporter System, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+15/HEK-Blue+IL-2+Cells/10__1158_slash_2326___6066__cir___26___0459-101-9-13
    Average 97 stars, based on 1 article reviews
    hek blue il 2 reporter system - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    Image Search Results


    (A) Abundance plots for co-occurring CD8+ T cell and Tnc -Hi iFB states nominated by proportionality network in Fig 2J. (B) Violin plot showing expression of T1 and T2 cytokine receptors along with selected differentially expressed markers of iFB states. (C) Flow cytometry was used to determine IL-15Rα positivity across CD31+ endothelial, CD45+ immune, PDGFRα+ fibroblasts and Ep-CAM+ epithelial cells (n=4 mice). Schematic and D37 ear thickness of IL-15 blockade prior to T2 memory (n=8 mice/group). Abundance of CD8+ T cells in D37 skin measured by flow cytometry (n=5 (Iso), 4 (α-IL-15) mice). (F) gMFI of IL-15-mediated support markers GZMB , IFNγ and Ki-67 in CD103+ and CD103-CD8+ T cells on D37 (n=3 (Iso), 4 (α-IL-15) mice). (G) Schematic of primary ear skin fibroblast isolation for cytokine stimulation. Heatmap of Il15ra and Il15 expression scaled as z-score across cytokine stimulation conditions (n=4 (IFNγ/TNF-α), 8 (single cytokine) mice). (H) Representative pSTAT1 staining in D37 skin from PDGFRα-eGFP mice. Yellow arrowheads denote pSTAT1+ PDGFRα+ fibroblasts. Schematic of intradermal AAV administration for STAT1 signaling modulation prior to T2 recall with associated ear thicknesses on D37 (n=7 (GFP, STAT1ca), 6 (STAT1dn) mice). FLAG-STAT1ca+ PDGFRa+ fibroblasts were compared with FLAG-untransduced fibroblasts for IL-15Rα gMFI on D37 (n=4 mice). (K) Frequency of GZMB positivity (n=11(GFP), 8 (STAT1ca) mice) and (L) GZMB gMFI were measured in CD103+ Trm cells and CD103-recruited cells on D37 in AAV-injected mice (n=15 (GFP), 12 (STAT1ca) mice). (M) UMAP embedding of 97,393 fibroblasts across 70 patients and 5 studies where subtypes are annotated (reticular rFB, papillary pFB, immune-interacting iiFB, nerve-associated nFB and hair follicle-associated hFB) and clusters are coloured. Study information is provided in and cluster definitions in . (N) Mapping of the top 50 genes defining murine Tnc -Hi iFB subtype as a gene module across human fibroblast clusters using patient-level pseudobulk GSVA. (O) Cell cluster abundances were correlated against vIGA-AD scores. Significant associations are highlighted. (P) Quantification of IL4I1 + pFB abundance in biopsies across healthy (H), non-lesional (NL) and lesional (L) skin (n=19 (H), 20 (NL), 31 (L) patients). (Q) Violin plot of genes stimulated by T2 and T1 effector cytokines across severity-associated human fibroblast clusters.

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: (A) Abundance plots for co-occurring CD8+ T cell and Tnc -Hi iFB states nominated by proportionality network in Fig 2J. (B) Violin plot showing expression of T1 and T2 cytokine receptors along with selected differentially expressed markers of iFB states. (C) Flow cytometry was used to determine IL-15Rα positivity across CD31+ endothelial, CD45+ immune, PDGFRα+ fibroblasts and Ep-CAM+ epithelial cells (n=4 mice). Schematic and D37 ear thickness of IL-15 blockade prior to T2 memory (n=8 mice/group). Abundance of CD8+ T cells in D37 skin measured by flow cytometry (n=5 (Iso), 4 (α-IL-15) mice). (F) gMFI of IL-15-mediated support markers GZMB , IFNγ and Ki-67 in CD103+ and CD103-CD8+ T cells on D37 (n=3 (Iso), 4 (α-IL-15) mice). (G) Schematic of primary ear skin fibroblast isolation for cytokine stimulation. Heatmap of Il15ra and Il15 expression scaled as z-score across cytokine stimulation conditions (n=4 (IFNγ/TNF-α), 8 (single cytokine) mice). (H) Representative pSTAT1 staining in D37 skin from PDGFRα-eGFP mice. Yellow arrowheads denote pSTAT1+ PDGFRα+ fibroblasts. Schematic of intradermal AAV administration for STAT1 signaling modulation prior to T2 recall with associated ear thicknesses on D37 (n=7 (GFP, STAT1ca), 6 (STAT1dn) mice). FLAG-STAT1ca+ PDGFRa+ fibroblasts were compared with FLAG-untransduced fibroblasts for IL-15Rα gMFI on D37 (n=4 mice). (K) Frequency of GZMB positivity (n=11(GFP), 8 (STAT1ca) mice) and (L) GZMB gMFI were measured in CD103+ Trm cells and CD103-recruited cells on D37 in AAV-injected mice (n=15 (GFP), 12 (STAT1ca) mice). (M) UMAP embedding of 97,393 fibroblasts across 70 patients and 5 studies where subtypes are annotated (reticular rFB, papillary pFB, immune-interacting iiFB, nerve-associated nFB and hair follicle-associated hFB) and clusters are coloured. Study information is provided in and cluster definitions in . (N) Mapping of the top 50 genes defining murine Tnc -Hi iFB subtype as a gene module across human fibroblast clusters using patient-level pseudobulk GSVA. (O) Cell cluster abundances were correlated against vIGA-AD scores. Significant associations are highlighted. (P) Quantification of IL4I1 + pFB abundance in biopsies across healthy (H), non-lesional (NL) and lesional (L) skin (n=19 (H), 20 (NL), 31 (L) patients). (Q) Violin plot of genes stimulated by T2 and T1 effector cytokines across severity-associated human fibroblast clusters.

    Article Snippet: For IL-15 neutralization, mice received a single 0.25 mg dose of anti-IL-15 antibody (BioXCell BE0315) one day before secondary MC903.

    Techniques: Expressing, Flow Cytometry, Isolation, Staining, Injection

    (A) Stacked bar plot showing representation of 15 scRNA-seq fibroblast clusters across T2 inflammation timepoints. (B-D) Flow cytometric evaluation of (B) CD103+ CD8+ Trm counts (n=8 (Iso), 9 (α-IL15) mice), (C) CD8+ T cell proportions (n=5 (Iso), 4 (α-IL15) mice), and (D) frequency of GZMB + CD8+ Trm (n=3 (Iso), 4 (α-IL15) mice) in skin at D37 after IL-15 neutralization before T2 memory recall. (E) Schematic of intradermal AAV injection with CAG-mCherry genome and flow cytometric assessment of PDGFRα+ and CD31+ cell tropism in skin after 3 days (n=4 mice). (F) Schematic for generating and stimulating 3T3 stable cell lines with doxycycline-inducible GFP, STAT1ca and STAT1dn plasmids in piggyBac vectors. Heatmap showing significant 24-hour transcriptional changes assessed by bulk RNA-seq (n=3 biological replicates/condition). (G) PCA of stably transfected 3T3 cell lines stimulated with IFNγ for 0 or 24 hours with or without 4-hour prior doxycycline induction for expression of STAT1 variant.

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: (A) Stacked bar plot showing representation of 15 scRNA-seq fibroblast clusters across T2 inflammation timepoints. (B-D) Flow cytometric evaluation of (B) CD103+ CD8+ Trm counts (n=8 (Iso), 9 (α-IL15) mice), (C) CD8+ T cell proportions (n=5 (Iso), 4 (α-IL15) mice), and (D) frequency of GZMB + CD8+ Trm (n=3 (Iso), 4 (α-IL15) mice) in skin at D37 after IL-15 neutralization before T2 memory recall. (E) Schematic of intradermal AAV injection with CAG-mCherry genome and flow cytometric assessment of PDGFRα+ and CD31+ cell tropism in skin after 3 days (n=4 mice). (F) Schematic for generating and stimulating 3T3 stable cell lines with doxycycline-inducible GFP, STAT1ca and STAT1dn plasmids in piggyBac vectors. Heatmap showing significant 24-hour transcriptional changes assessed by bulk RNA-seq (n=3 biological replicates/condition). (G) PCA of stably transfected 3T3 cell lines stimulated with IFNγ for 0 or 24 hours with or without 4-hour prior doxycycline induction for expression of STAT1 variant.

    Article Snippet: For IL-15 neutralization, mice received a single 0.25 mg dose of anti-IL-15 antibody (BioXCell BE0315) one day before secondary MC903.

    Techniques: Neutralization, Injection, Stable Transfection, RNA Sequencing, Transfection, Expressing, Variant Assay

    Primary allergic inflammation induced by MC903 initiates a TSLP-driven keratinocyte response that promotes a T2 environment driven by IL-4 and IL-13 secretion from Th2 cells and basophils. Upon recovery, epidermal-resident allergic CD8+ Trm cells, a reservoir of inflammatory memory, are established in murine skin. Upon T2 recall, a mixed inflammatory environment is established with rapid recruitment of T1 and T2 effectors. Re-activated allergic CD8+ Trm cells producing IFNγ, TNF-α and IL-13 drive this T2-to-T1 shift in memory and form a two-cell circuit with dermal fibroblasts. Responding to CD8+ Trm-derived T1 effector cytokines, fibroblasts trans-present IL-15 to enhance the effector profile of CD8+ T cells, and recruit circulating T cells via CCL19 secretion. Concurrent IL-4 signaling potentiates both amplification arms of the fibroblast–CD8+ T cell circuit.

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: Primary allergic inflammation induced by MC903 initiates a TSLP-driven keratinocyte response that promotes a T2 environment driven by IL-4 and IL-13 secretion from Th2 cells and basophils. Upon recovery, epidermal-resident allergic CD8+ Trm cells, a reservoir of inflammatory memory, are established in murine skin. Upon T2 recall, a mixed inflammatory environment is established with rapid recruitment of T1 and T2 effectors. Re-activated allergic CD8+ Trm cells producing IFNγ, TNF-α and IL-13 drive this T2-to-T1 shift in memory and form a two-cell circuit with dermal fibroblasts. Responding to CD8+ Trm-derived T1 effector cytokines, fibroblasts trans-present IL-15 to enhance the effector profile of CD8+ T cells, and recruit circulating T cells via CCL19 secretion. Concurrent IL-4 signaling potentiates both amplification arms of the fibroblast–CD8+ T cell circuit.

    Article Snippet: For IL-15 neutralization, mice received a single 0.25 mg dose of anti-IL-15 antibody (BioXCell BE0315) one day before secondary MC903.

    Techniques: Derivative Assay, Amplification

    A. Schematic for MHC Class I immunoprecipitation from B16-F10, B16-(shRNA-AIRE), and B16-F10-(AIRE) cells using the Clone Y-3 anti-H-2K b antibody (Created in BioRender. Chen, A. (2026) https://BioRender.com/grw7tkh ). B. C57BL/6 mice with 5 day-established B16-F10 tumors (n=8 mice per group) were treated with dendritic cells loaded in vitro with SIINFEKL peptide (1 μg per 1 × 10 6 DC/injection) with PBS or with peptide sets of the Unique, Shared, Longer peptides (see Table 1 ) (at 0.25 μg per peptide, total 1 μg per 1 × 10 6 DC/injection) on days 5, 7 & 9. Mice were then treated with anti-PD-1 antibody or isotype IgG control as shown on days 12, 14, 16 and 19, 21, 23. For clarity, survival and tumor volume with time are shown for groups treated with control IgG (no ICB) ( B ) or with ICB ( C ) ( B & C are the same experiment). D. CD8 + T cells (1 × 10 6 /well) were isolated from mice at endpoint in B/C. (4/group) which had been treated with DC vaccines loaded with different peptides and co-treated with anti-PD-1 as shown. 1 × 10 6 CD8 + T cells were re-stimulated in 96-well ELISPOT plates (4 biological triplicates shown) with either 5 × 10 5 live target cells (B16-F10 or B16-F10-(AIRE) (pre-treated with IFN-γ for 24 hours to increase MHC class I expression) or with either 5 × 10 5 dendritic cells loaded with the Unique, Shared, Longer peptide sets or SIINFEKL peptide (total of 1 μg peptide/10 6 DC) for 48 hours at 37°C. IFN-γ positive spots were quantified by computer assisted image analyzer. Mean values are shown for four biological triplicates and error bars represent standard deviation of the mean. E. CD4 + T cells were isolated by magnetic bead sorting from mice at endpoint in B/C (3/group) which had been treated with DC vaccines loaded with different peptides and co-treated with anti-PD-1 as shown. 5 × 10 5 CD4 + T cells were re-stimulated in 96-well plates (3 biological triplicates shown) with 5 × 10 5 dendritic cells loaded with the Longer ( i ), Shared ( ii ), or Unique ( iii ) peptide sets (total of 1 μg peptide/10 6 DC) for 48 hours at 37°C. 48 hours later IL-15 in the supernatant was measured by ELISA (Bio-Techne, R&D Systems; Mouse IL-15 DuoSet ELISA; Cat# DY447). Mean values are shown for three biological triplicates and error bars represent standard deviation of the mean. Gehan-Breslow-Wilcoxon statistical tests for survival were used for B & C , and ordinary one-way ANOVA statistical tests were used to analyze D & E (α=0.05).

    Journal: Cancer immunology research

    Article Title: Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome

    doi: 10.1158/2326-6066.CIR-25-1589

    Figure Lengend Snippet: A. Schematic for MHC Class I immunoprecipitation from B16-F10, B16-(shRNA-AIRE), and B16-F10-(AIRE) cells using the Clone Y-3 anti-H-2K b antibody (Created in BioRender. Chen, A. (2026) https://BioRender.com/grw7tkh ). B. C57BL/6 mice with 5 day-established B16-F10 tumors (n=8 mice per group) were treated with dendritic cells loaded in vitro with SIINFEKL peptide (1 μg per 1 × 10 6 DC/injection) with PBS or with peptide sets of the Unique, Shared, Longer peptides (see Table 1 ) (at 0.25 μg per peptide, total 1 μg per 1 × 10 6 DC/injection) on days 5, 7 & 9. Mice were then treated with anti-PD-1 antibody or isotype IgG control as shown on days 12, 14, 16 and 19, 21, 23. For clarity, survival and tumor volume with time are shown for groups treated with control IgG (no ICB) ( B ) or with ICB ( C ) ( B & C are the same experiment). D. CD8 + T cells (1 × 10 6 /well) were isolated from mice at endpoint in B/C. (4/group) which had been treated with DC vaccines loaded with different peptides and co-treated with anti-PD-1 as shown. 1 × 10 6 CD8 + T cells were re-stimulated in 96-well ELISPOT plates (4 biological triplicates shown) with either 5 × 10 5 live target cells (B16-F10 or B16-F10-(AIRE) (pre-treated with IFN-γ for 24 hours to increase MHC class I expression) or with either 5 × 10 5 dendritic cells loaded with the Unique, Shared, Longer peptide sets or SIINFEKL peptide (total of 1 μg peptide/10 6 DC) for 48 hours at 37°C. IFN-γ positive spots were quantified by computer assisted image analyzer. Mean values are shown for four biological triplicates and error bars represent standard deviation of the mean. E. CD4 + T cells were isolated by magnetic bead sorting from mice at endpoint in B/C (3/group) which had been treated with DC vaccines loaded with different peptides and co-treated with anti-PD-1 as shown. 5 × 10 5 CD4 + T cells were re-stimulated in 96-well plates (3 biological triplicates shown) with 5 × 10 5 dendritic cells loaded with the Longer ( i ), Shared ( ii ), or Unique ( iii ) peptide sets (total of 1 μg peptide/10 6 DC) for 48 hours at 37°C. 48 hours later IL-15 in the supernatant was measured by ELISA (Bio-Techne, R&D Systems; Mouse IL-15 DuoSet ELISA; Cat# DY447). Mean values are shown for three biological triplicates and error bars represent standard deviation of the mean. Gehan-Breslow-Wilcoxon statistical tests for survival were used for B & C , and ordinary one-way ANOVA statistical tests were used to analyze D & E (α=0.05).

    Article Snippet: Cell-free supernatants were collected after 48 hours and tested by ELISA for murine IL-15 (Bio-Techne, R&D Systems; Mouse IL-15 DuoSet ELISA; Cat# DY447).

    Techniques: Over Expression, Immunoprecipitation, shRNA, In Vitro, Injection, Control, Isolation, Vaccines, Enzyme-linked Immunospot, Expressing, Standard Deviation, 96 Well Plates, Enzyme-linked Immunosorbent Assay, Liquid Chromatography with Mass Spectroscopy, Tandem Mass Spectroscopy